Evidence map›Paper›PMID 11531942›Full record

ArticleClinical and experimental immunology2001

C1q-bearing immune complexes induce IL-8 secretion in human umbilical vein endothelial cells (HUVEC) through protein tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms: evidence that the 126 kD phagocytic C1q receptor mediates immune complex activation of HUVEC.

S Xiao, C Xu, J N Jarvis

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neutrophils: the forgotten cell in JIA disease pathogenesis.Pediatric rheumatology online journal · 2007
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S XiaoDepartment of Pedatrics, Rheumatology Research, University of Oklahoma Health Sciences Center and the Children's Hospital of Oklahoma, Oklahoma City, 73104, USA.
C Xu
J N Jarvis
University of Oklahoma Health Sciences Center · USChildren's Hospital of Oklahoma · US

Funding

IMMUNE COMPLEXES IN THE PATHOPHYSIOLOGY OF JRAR01AR043967 · NIAMS · WAYNE STATE UNIVERSITY · PI JARVIS, JAMES N · 1995 to 1997
–
NIAMS NIH HHS AR-43967
6 · The paper itself

Abstract

Endothelial cells play a pivotal role in the initiation and perpetuation of inflammation. C1q, the first component of the classical pathway of complement, is a potent stimulus leading to endothelial cell activation and cytokine production. The specific cellular mechanisms through which endothelial cells are stimulated by C1q are not known. We stimulated human umbilical vein endothelial cells (HUVEC) with either monomeric C1q or C1q-bearing immune complexes (C1q-IC) in the presence or absence of inhibitors of protein tyrosine kinases (PTK) or mitogen-activated protein kinases (MAPK). C1q-IC, but not monomeric C1q, induced IL-8 production in dose- and time-dependent fashion. R3, a cross-linking monoclonal IgM antibody against the 126 kD phagocytic C1q receptor (C1qR), also stimulated IL-8 production. IL-8 mRNA accumulation was detected by Northern blot analysis within 2 h of stimulation by the immune complexes and was enhanced by the addition of cycloheximide. Secretion of IL-8 by C1q-IC stimulated HUVEC was completely blocked by the PTK inhibitor, genistein or the MAPK inhibitor, UO126. These experiments demonstrate that C1q-IC-induced production of IL-8 in HUVEC is dependent upon the activation of PTK and MAPK. These findings also support a role for the phagocytic C1qR as an important activator of HUVEC by immune complexes.

Indexed as

Hyaluronan ReceptorsMembrane GlycoproteinsAntigen-Antibody ComplexButadienesCarrier ProteinsComplement C1qComplement Pathway, ClassicalEndothelium, VascularGenisteinHumansInterleukin-8Mitochondrial ProteinsMitogen-Activated Protein KinasesNitrilesPhagocytosisProtein-Tyrosine KinasesAntigen-Antibody ComplexButadienesC1QBP protein, humanCarrier Proteinscomplement 1q receptorComplement C1qGenisteinHyaluronan ReceptorsInterleukin-8Membrane GlycoproteinsMitochondrial ProteinsMitogen-Activated Protein KinasesNitrilesProtein-Tyrosine KinasesReceptors, ComplementU 0126

Identifiers

PMID11531942
PMCPMC1906143
OpenAlexW1977789393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.